Aclidinium
Back to searchMolecule Structure
Scientific Name
Aclidinium
Description of the Drug
Aclidinium is an inhaled long-acting anticholinergic used as a maintenance bronchodilator in patients with chronic obstructive pulmonary disease (COPD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08897
http://www.drugbank.ca/drugs/DB08897
Brand Name(s)
Not Available
Company Owner(s)
Covis Pharma Gmbh
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL72141 | |
| DrugBank | DB08897 | |
| PubChem | 11434515 | |
| LINCS | LSM-45884 | |
| Nikkaji | J3.278.980C | |
| BindingDB | 50296331 | |
| EPA CompTox Dashboard | DTXSID00223070 | |
| DrugCentral | 4484 | |
| Guide to Pharmacology | 7449 | |
| rxnorm | ACLIDINIUM BROMIDE | ACLIDINIUM |
| ChEBI | 65346 | |
| ZINC | ZINC000030691727 |
